Globe size and bevacizumab treatment in retinopathy of prematurity: should we adjust the dose? – (Eye 30, 1401 (November 2016))
Globe size and bevacizumab treatment in retinopathy of prematurity: should we adjust the dose? Eye 30, 1401 (November 2016). doi:10.1038/eye.2016.173 Authors: A J Connor & A Shafiq
Report suspected side effects to help make medicines safer
The Medicines and Healthcare products Regulatory Agency (MHRA) is running a social media campaign between 7-11 November to promote reporting of suspected side effects, as part of an EU-wide awareness week. Medicines have the potential to harm as well as cure. While they are usually safe and effective, side effects can happen. It is important
MPs and Peers pledge support for equal access for all eye patients to timely treatment to prevent loss of vision
The Royal College of Ophthalmologists (RCOphth) hosted a successful parliamentary reception at Westminster on the 2 November. Over 35 MPs and Peers met with members of the Royal College to learn about the demand placed on hospital eye services and the impact on patients. MPs and Peers were asked to give their pledge to support
RCOphth/COECSA Training the Trainers paper wins THET Prize
Over 40 paper presentations described a wide variety of health-related projects from around the developing world at the The Tropical Health Education Trust (THET) Conference 2016, with the RCOphth/ COECSA Training the Trainers paper commended as the winning presentation. The event was a national conference focusing on “Evidence, Effectiveness and Impact” in Partnerships for Global Health.
Comment on ‘Comparison of subthreshold micropulse laser (577 nm) treatment and half-dose photodynamic therapy in patients with chronic central serous chorioretinopathy’ – (Eye Journal AOP)
Comment on ‘Comparison of subthreshold micropulse laser (577 nm) treatment and half-dose photodynamic therapy in patients with chronic central serous chorioretinopathy’ Eye advance online publication, November 4 2016. doi:10.1038/eye.2016.242 Authors: E H C van Dijk & C J F Boon